Elliptic Laboratories AS
BalancedELABS·XOSL·🇳🇴 NO
50%buys·50%sales
7 transactions$0Total buys·0 buys
$0Total sells·0 sells
77 insiders
Last: Mar 27, 2026
| Date | Insider | Type | Value | |
|---|---|---|---|---|
| Mar 27, 26 | Mathias Norderud | Subscription | - | |
| Mar 27, 26 | TS Vekst AS | Subscription | - | |
| Mar 27, 26 | Berit Svendsen | Subscription | - | |
| Mar 27, 26 | INGRID ELVIRA LEISNER | Subscription | - | |
| Mar 27, 26 | Svein-Egil Nielsen | Subscription | - | |
| Mar 27, 26 | Svenn-Tore Larsen | Subscription | - | |
| Mar 27, 26 | Alden AS | Subscription | - |
Elliptic Laboratories AS (ELABS) has recorded 7 insider transactions from 7 insiders. Total insider buying volume stands at $0, while total selling volume is $0. Insider activity shows a balanced mix of buying and selling.
Elliptic Laboratories AS (ELABS) has recorded 7 insider operations, including 0 open-market purchases ($0), 0 sales ($0) and 7 other operations (stock option exercises, grants, tax dispositions, donations). The insider sentiment is balanced.
Recent activity is concentrated over 1 months in the last year.
Among the most active insiders are TS Vekst AS (CEO), Mathias Norderud (CFO) & Svenn-Tore Larsen (CHAIRMAN), with respectively 1, 1, 4 transactions.
Data sourced from regulatory filings (SEC Form 4, AMF, BaFin, FI, and other European authorities).
Elliptic Laboratories AS has recorded 7 insider operations in total, including 0 open-market purchases ($0), 0 sales ($0) and 7 other operations (stock option exercises, grants, tax dispositions, donations). The most recent transaction was recorded on March 27, 2026.
Insiders at Elliptic Laboratories AS show balanced activity with 50% purchases and 50% sales. Total buy volume is $0 versus $0 in sales.
InsiderLens tracks 7 insiders at Elliptic Laboratories AS (ELABS). TS Vekst AS (CEO, 1 tx), Mathias Norderud (CFO, 1 tx), Svenn-Tore Larsen (CHAIRMAN, 4 tx). Data is sourced from mandatory regulatory filings for persons with access to privileged information.
The insider signal for ELABS is neutral, based on a 50% buy ratio across 0 buy and sell transactions reported to financial regulators. Transactions from C-suite executives (CEO, CFO) and board members are generally considered the most informative signals.
Insider trading data for Elliptic Laboratories AS comes from official regulatory filings: SEC Form 4 (United States), AMF (France), BaFin (Germany), FI (Sweden), and other European financial authorities. These filings are mandatory for directors, officers, and holders of more than 10% of a company's shares. InsiderLens aggregates and normalizes this data for analysis.